The Child Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in diagnosing pediatric bipolar disorder.

abstract：PURPOSE:The aim of this study was to explore relationships between the Children's Depression Rating Scale-Revised (CDRS-R) and Hamilton Rating Scale for Depression (HAM-D) in adolescent bipolar disorder. We hypothesized that CDRS-R and HAM-D scores would be significantly correlated and both scales would be sensitive to...

journal_title：Journal of child and adolescent psychopharmacology

authors： Patel NC,DelBello MP,Kowatch RA,Strakowski SM

更新日期：2006-06-01 00:00:00

abstract：:In clinical samples, juvenile bipolar disorder (JBPD) is frequently accompanied by co-morbid attention-deficit/hyperactivity disorder (ADHD). Clinical trials assessing combined psychopharmacological interventions in this population are scarce, and methylphenidate (MPH) may worsen manic symptoms. We conducted a randomi...

journal_title：Journal of child and adolescent psychopharmacology

authors： Zeni CP,Tramontina S,Ketzer CR,Pheula GF,Rohde LA

更新日期：2009-10-01 00:00:00

abstract：:The study assessed competencies and practices of a large group of healthcare providers in childhood attention-deficit/hyperactivity disorder (ADHD), and identified barriers to improving care. Methods were self-assessment using an Internet questionnaire with a standardized patient case; analysis compared with professio...

journal_title：Journal of child and adolescent psychopharmacology

authors： Brown JJ,Hertzer JL,Findling RL

更新日期：2011-02-01 00:00:00

abstract：:A 10-year-old boy with a history of heart transplantation had a potentially life-threatening decrease in his cyclosporine (CSA) blood levels during administration of bupropion. Subsequently he had an increase in CSA levels while receiving methylphenidate. These occurrences represent potential drug-drug interactions in...

journal_title：Journal of child and adolescent psychopharmacology

authors： Lewis BR,Aoun SL,Bernstein GA,Crow SJ

更新日期：2001-07-01 00:00:00

abstract：OBJECTIVES:The characterization and prediction of placebo response in clinical trials of youth with anxiety disorders have received little attention, despite the critical effects of placebo response rate on the success or failure of clinical trials. With this in mind, we sought to examine the factors that predict or in...

journal_title：Journal of child and adolescent psychopharmacology

authors： Dobson ET,Strawn JR

更新日期：2016-10-01 00:00:00

abstract：:Current estimates suggest that between 0.4% and 8.3% of children and adolescents are affected by major depression. We report a favorable response to treatment with citalopram by a 15-year-old boy with major depression who exhibited palpebral twitching during his first 2 weeks of treatment. This may have been a side ef...

journal_title：Journal of child and adolescent psychopharmacology

authors： Rojas VM,Silva R

更新日期：2001-10-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to evaluate the short- and long-term efficacy and safety of ziprasidone in children and adolescents with bipolar I disorder. METHODS:Subjects 10-17 years of age with a manic or mixed episode associated with bipolar I disorder participated in a 4 week, randomized, double-blind, p...

journal_title：Journal of child and adolescent psychopharmacology

authors： Findling RL,Cavuş I,Pappadopulos E,Vanderburg DG,Schwartz JH,Gundapaneni BK,DelBello MP

更新日期：2013-10-01 00:00:00

abstract：OBJECTIVE:Recent research suggests that not only parental psychopathology, but also parenting practices, have a role to play in the development of child posttraumatic stress symptoms (PTSS) following a natural disaster. The current study aimed to investigate the relationship between parents' perceptions of their parent...

journal_title：Journal of child and adolescent psychopharmacology

authors： Cobham VE,McDermott B

更新日期：2014-02-01 00:00:00

abstract：: Objective: To examine the role of Guanfacine Extended Release (GXR) in the management of behavioral disturbances in patients with Prader-Willi Syndrome (PWS). Methods: Twenty from a total of 27 individuals with genetically conf...

journal_title：Journal of child and adolescent psychopharmacology

authors： Singh D,Wakimoto Y,Filangieri C,Pinkhasov A,Angulo M

更新日期：2019-05-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to present the reliability and validity of the Children's Depression Rating Scale-Revised (CDRS-R) in the adolescent age group. METHOD:Adolescents with symptoms of depression were assessed using the CDRS-R and global severity and functioning scales at screening, baseline, and after ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Mayes TL,Bernstein IH,Haley CL,Kennard BD,Emslie GJ

更新日期：2010-12-01 00:00:00

abstract：OBJECTIVES:To evaluate the 52-week safety/tolerability of oral olanzapine for adolescents with schizophrenia or bipolar mania and compare effectiveness of a standard versus intense behavioral weight intervention in mitigating risk of weight gain. METHODS:Patients 13-17 years old with schizophrenia (Brief Psychiatric R...

journal_title：Journal of child and adolescent psychopharmacology

authors： Detke HC,DelBello MP,Landry J,Hoffmann VP,Heinloth A,Dittmann RW

更新日期：2016-12-01 00:00:00

abstract：OBJECTIVE:The striatum, including the putamen and caudate, plays an important role in executive and emotional processing and may be involved in the pathophysiology of mood disorders. Few studies have examined structural abnormalities of the striatum in pediatric major depressive disorder (MDD) patients. We report stria...

journal_title：Journal of child and adolescent psychopharmacology

authors： Matsuo K,Rosenberg DR,Easter PC,MacMaster FP,Chen HH,Nicoletti M,Caetano SC,Hatch JP,Soares JC

更新日期：2008-04-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to conduct a prospective safety and tolerability study of aripiprazole for the treatment of tics in children and adolescents with Tourette's disorder (TD). METHOD:Eleven subjects (10 males) with TD (age 9-19 years, mean 13.36, standard deviation [SD] 3.33) who did not respond or wer...

journal_title：Journal of child and adolescent psychopharmacology

authors： Lyon GJ,Samar S,Jummani R,Hirsch S,Spirgel A,Goldman R,Coffey BJ

更新日期：2009-12-01 00:00:00

abstract：:Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood...

journal_title：Journal of child and adolescent psychopharmacology

authors： Hah M,Chang K

更新日期：2005-12-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to investigate the course of autistic symptoms, using a quantitative measure of core autistic traits, among risperidone-treated children who participated in a 10 year life course longitudinal study. METHODS:Parents completed surveys of intervention history, as well as serial sym...

journal_title：Journal of child and adolescent psychopharmacology

authors： Marrus N,Underwood-Riordan H,Randall F,Zhang Y,Constantino JN

更新日期：2014-11-01 00:00:00

abstract：:This article surveys the development of human hepatic P450 cytochromes (CYPs) involved in xenobiotic metabolism from the fetus through the life span and explores possible clinical consequences of developmental issues. These hepatic P450 CYPs come "on line" at different times during fetal and infant development, and ea...

journal_title：Journal of child and adolescent psychopharmacology

authors： Oesterheld JR

更新日期：1998-01-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to describe the special considerations for building rapport and establishing a therapeutic alliance when conducting mental health evaluations for children and adolescents via videoconferencing. METHODS:The authors review the literature and describe their experience in conducting...

journal_title：Journal of child and adolescent psychopharmacology

authors： Goldstein F,Glueck D

更新日期：2016-04-01 00:00:00

abstract：OBJECTIVE:Edivoxetine (LY2216684) is a selective and potent norepinephrine reuptake inhibitor (NERI). The pharmacokinetics (PK) and pharmacodynamics (PD) of edivoxetine were assessed in children and adolescent patients with attention-deficit/hyperactivity disorder (ADHD) following single and once-daily oral doses of ed...

journal_title：Journal of child and adolescent psychopharmacology

authors： Kielbasa W,Quinlan T,Jin L,Xu W,Lachno DR,Dean RA,Allen AJ

更新日期：2012-08-01 00:00:00

abstract：:The potential for the induction of mania, increased cycle frequency, and other behavioral adverse events associated with antidepressant exposure in patients with bipolar disorder is becoming an increasingly important area of research study, as this diagnosis receives wider recognition in youth. While the majority of s...

journal_title：Journal of child and adolescent psychopharmacology

authors： Papolos DF

更新日期：2003-07-01 00:00:00

abstract：BACKGROUND:Despite its high chronicity, few studies have evaluated the effectiveness of long-term treatment for pediatric obsessive-compulsive disorder (OCD). The goal of the current analysis is to evaluate remission among children and adolescents with OCD treated with sertraline for 12 months. METHODS:Children (6-12 ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Wagner KD,Cook EH,Chung H,Messig M

更新日期：2003-01-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to evaluate the efficacy and safety of acute quetiapine monotherapy in adolescents with schizophrenia. METHODS:Patients ages 13-17 years with an American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR) diagnosis ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Findling RL,McKenna K,Earley WR,Stankowski J,Pathak S

更新日期：2012-10-01 00:00:00

abstract：OBJECTIVE:To describe the methodological challenges and decisions made in developing a multisite, controlled study of risperidone in children and adolescents with autism. METHODS:Review the design considerations for clinical trials in children with autistic disorder accompanied by severe tantrums, aggressive and/or se...

journal_title：Journal of child and adolescent psychopharmacology

authors： Scahill L,McCracken J,McDougle CJ,Aman M,Arnold LE,Tierney E,Cronin P,Davies M,Ghuman J,Gonzalez N,Koenig K,Lindsay R,Martin A,McGough J,Posey DJ,Swiezy N,Volkmar F,Ritz L,Vitiello B

更新日期：2001-01-01 00:00:00

abstract：OBJECTIVE:This study examined the effects of pediatric anxiety and its interaction with gender on reward processes. Based on the purported greater sensitivity to risk in females than males and the propensity for risk aversion in anxiety, clinical anxiety and female gender were hypothesized to act synergistically in red...

journal_title：Journal of child and adolescent psychopharmacology

authors： Dorfman J,Rosen D,Pine D,Ernst M

更新日期：2016-05-01 00:00:00

abstract：:This meta-analysis assessed aggression and/or hostility-related events in children and adolescents treated with fluoxetine (n = 376) compared with placebo (n = 255). Aggression and/or hostility-related events were identified in 2.1% of fluoxetine versus 3.1% of placebo-treated patients (p = 0.588). This analysis fails...

journal_title：Journal of child and adolescent psychopharmacology

authors： Tauscher-Wisniewski S,Nilsson M,Caldwell C,Plewes J,Allen AJ

更新日期：2007-10-01 00:00:00

abstract：OBJECTIVE:Concerns about serious cardiovascular (CV) events among stimulant-treated youth have led to clinical and policy debates. Accordingly, several population-based empirical studies have assessed the risk of CV events in children and adolescents treated with stimulants. The main objective of this review was to sum...

journal_title：Journal of child and adolescent psychopharmacology

authors： Zito JM,Burcu M

更新日期：2017-08-01 00:00:00

abstract：INTRODUCTION:The antipsychotic drugs are the best-studied agents shown to reduce symptoms in autism, including hyperactivity, aggression, self-abusive behavior, temper tantrums, lability, irritability, social withdrawal, and stereotypical behaviors. However, significant weight gain has been associated with use of many ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Malone RP,Delaney MA,Hyman SB,Cater JR

更新日期：2007-12-01 00:00:00

abstract：: Objective: The goal of this study was to characterize the frequency and trends of psychotropic drug prescribing in Canadian children from 2010 to 2016 and to compare these results with a previous study conducted between 2005 and 2009. Methods: ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Pringsheim T,Stewart DG,Chan P,Tehrani A,Patten SB

更新日期：2019-12-01 00:00:00

abstract：OBJECTIVE:A recent 12-week controlled comparison demonstrated the superiority of clozapine to "high-dose" olanzapine in adolescents with treatment-refractory schizophrenia. In the present study, the authors conducted a 12-week, open-label, follow-up study to examine changes in lipid and glucose metabolism in youths mai...

journal_title：Journal of child and adolescent psychopharmacology

authors： Kumra S,Kranzler H,Gerbino-Rosen G,Kester HM,DeThomas C,Cullen K,Regan J,Kane JM

更新日期：2008-08-01 00:00:00

abstract：OBJECTIVES:The aim of this study is to identify predictors of pill placebo response and to characterize the temporal course of pill placebo response in anxious youth. METHODS:Data from placebo-treated patients (N = 76) in the Child/Adolescent Anxiety Multimodal Study (CAMS), a multisite, randomized controlled trial th...

journal_title：Journal of child and adolescent psychopharmacology

authors： Strawn JR,Dobson ET,Mills JA,Cornwall GJ,Sakolsky D,Birmaher B,Compton SN,Piacentini J,McCracken JT,Ginsburg GS,Kendall PC,Walkup JT,Albano AM,Rynn MA

更新日期：2017-08-01 00:00:00

abstract：:Autism spectrum disorder (ASD) is commonly associated with a host of challenging behaviors. Pharmacotherapy is indicated if psychosocial and educational interventions fail. Atypical antipsychotics have the strongest evidence base so far, with both risperidone and aripiprazole being FDA approved. Unfortunately, their u...

journal_title：Journal of child and adolescent psychopharmacology

authors： Naguy A

更新日期：2017-06-01 00:00:00